| NCT ID | NCT07713797 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Trio Fertility |
| Condition | Endometriosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-01-16 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-01-16 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often causing pain and infertility. Currently, endometriosis can only be definitively diagnosed through invasive procedures like laparoscopy and biopsy. The purpose of this study is to investigate whether the proteins Synuclein Gamma (SNCG) and B-Cell Lymphoma 6 (BCL6), measurable in blood and menstrual fluid, can serve as non-invasive biomarkers to diagnose or monitor endometriosis.
Eligibility Criteria
Inclusion Criteria for Endometriosis Group: * Women of reproductive age group (18Y-45Y). * Women with active endometriosis diagnosed by ultrasound/MRI/laparoscopy. Exclusion Criteria for Endometriosis Group: * Women \<18Y and \>45Y. * Women with endometriosis during stimulation with gonadotropins. * Current or prior history of uterine, ovarian, colon, pancreatic, breast or any other type of cancer. * Any prior history of chronic illness. * Pregnant women. Inclusion Criteria for Control Group: * Women of reproductive age group (18Y-45Y). * Women without endometriosis and any other gynaecological problem. Exclusion Criteria for Endometriosis Group: * Women \<18Y and \>45Y * Prior history of any disease including cancer or chronic illness. * Pregnant women.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07713797 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07713797 currently recruiting?
Yes, NCT07713797 is actively recruiting participants. Contact the research team at yasamans@triofertility.com for enrollment information.
Where is the NCT07713797 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT07713797 clinical trial?
NCT07713797 is sponsored by Trio Fertility. The trial plans to enroll 100 participants.